Copyright
©The Author(s) 2020.
World J Gastroenterol. May 14, 2020; 26(18): 2138-2154
Published online May 14, 2020. doi: 10.3748/wjg.v26.i18.2138
Published online May 14, 2020. doi: 10.3748/wjg.v26.i18.2138
Figure 2 Proposal of a treatment algorithm for low-density lipoprotein cholesterol lowering strategy in liver transplant recipients.
1Class of recommendation: IIa; level of evidence: B, according to 2019 ESC/EAS Guidelines for the management of dyslipidaemias[118]. 2Class of recommendation: IIb; level of evidence: C, according to 2019 ESC/EAS Guidelines for the management of dyslipidaemias[118]. LDL-C: Low-density lipoprotein cholesterol.
- Citation: Becchetti C, Dirchwolf M, Banz V, Dufour JF. Medical management of metabolic and cardiovascular complications after liver transplantation. World J Gastroenterol 2020; 26(18): 2138-2154
- URL: https://www.wjgnet.com/1007-9327/full/v26/i18/2138.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i18.2138